VTCN1 Produkte
(V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
Kategorien
This gene encodes a protein belonging to the B7 costimulatory protein family. Proteins in this family are present on the surface of antigen-presenting cells and interact with ligand bound to receptors on the surface of T cells. Studies have shown that high levels of the encoded protein has been correlated with tumor progression. A pseudogene of this gene is located on chromosome 20. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte VTCN1 Kategorien
VTCN1 Antikörper
High quality antibodies with extensive validation data.
VTCN1 ELISA Kits
Reliable ELISA kits for a wide range of species.
VTCN1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene VTCN1 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
ELISA, FACS, IF (p), IF (cc), IHC (p), IHC (fro)
Validierungen
- (1)
- (7)
Kat. Nr.
ABIN671736
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IHC, IP, ICC
Validierungen
- (6)
Kat. Nr.
ABIN7436759
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, ELISA, IHC, FACS, IF, Coat, StM
Validierungen
- (5)
Kat. Nr.
ABIN6940936
Menge
100 μg
Datenblatt
Datenblatt
Empfohlene VTCN1 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
- (5)
Kat. Nr.
ABIN6574330
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6971108
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6976048
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene VTCN1 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
HEK-293 Cells
Validierungen
- (4)
Kat. Nr.
ABIN7273952
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
HEK-293 Cells
Validierungen
- (4)
Kat. Nr.
ABIN7273962
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
HEK-293 Cells
Validierungen
- (4)
Kat. Nr.
ABIN7273961
Menge
100 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren VTCN1 Produkten
: "The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma." in: Journal of cancer research and clinical oncology, (2022) (PubMed).: "Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus." in: Iranian journal of immunology : IJI, Vol. 16, Issue 1, pp. 43-52, (2019) (PubMed).
: "VISTA is an acidic pH-selective ligand for PSGL-1. ..." in: Nature, Vol. 574, Issue 7779, pp. 565-570, (2019) (PubMed).
: "Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 23, Issue 12, pp. 2934-2941, (2018) (PubMed).
: "Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer." in: Oncology letters, Vol. 11, Issue 4, pp. 2815-2819, (2016) (PubMed).
: "Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 196, Issue 4, pp. 1495-506, (2016) (PubMed).
: "Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients." in: Oncotarget, Vol. 7, Issue 47, pp. 77237-77243, (2016) (PubMed).
: "Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance." in: International journal of clinical oncology, Vol. 20, Issue 2, pp. 273-81, (2015) (PubMed).
: "B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity." in: Cancer immunology research, Vol. 3, Issue 2, pp. 184-95, (2015) (PubMed).
: "Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis." in: Tumour biology, (2014) (PubMed).
Synonyme und alternative Namen zu VTCN1
V set domain containing T cell activation inhibitor 1 L homeolog (vtcn1.L), V-set domain containing T cell activation inhibitor 1 (VTCN1), V-set domain containing T-cell activation inhibitor 1 (VTCN1), V set domain containing T cell activation inhibitor 1 (vtcn1), V-set domain containing T cell activation inhibitor 1 (Vtcn1), B7-H4, B7h.5, B7h4, B7H4, B7s1, B7S1, B7x, B7X, BC032925, PRO1291, RGD1311204, VCTN1Bezeichner auf Proteinebene für VTCN1
- V-set domain-containing T-cell activation inhibitor 1
- V-set domain containing T cell activation inhibitor 1
- V-set domain containing T-cell activation inhibitor 1
- immune costimulatory protein B7-H4
- t cell costimulatory molecule B7x
- B7 family member, H4
- B7 superfamily member 1
- T cell costimulatory molecule B7x
- T-cell costimulatory molecule B7x
Sie sind hier:
